Login to your account

Username *
Password *
Remember Me

Blog With Right Sidebar

Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry.

CONCLUSIONS: The IPF-PRO registry will improve understanding of the natural history of IPF, its impact on patients and current practice in the diagnosis and care of patients with IPF. The registry will establish a repository of biological samples from a well-characterised patient population for future research. CLINICAL TRIAL NUMBER: NCT01915511. PMID: 26835134 [PubMed] (Source: Respiratory Care)

Author:

Read Full Article

Search